Mr. Donald Allen Morrison Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1615 Michigan Ave, Baldwin, MI 49304 Phone: 231-745-5024 |
Matthew David Krawczak Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 868 Michigan Ave, Baldwin, MI 49304 Phone: 231-745-4697 |
Mr. Jeffrey Allan Bates, BS PHARM Pharmacist - Geriatric Medicare: Not Enrolled in Medicare Practice Location: 600 Denmark St, Baldwin, MI 49304 Phone: 231-745-4648 |
Hien Thanh-le Nguyen, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1615 Michigan Ave, Baldwin, MI 49304 Phone: 231-745-5024 |
News Archive
"Ten years after world leaders set the most ambitious goals ever to tackle global poverty, they are meeting again to try to spur action to meet the targets by the 2015 deadline - which the U.N. says will be difficult, if not impossible, in some cases," the Associated Press reports. More than 140 world leaders are scheduled to participate in the three-day U.N. Summit on the Millennium Development Goals (MDGs), which kicks off Monday.
Concuity, a Healthcare Division of Trintech, Inc., and a leading provider of Revenue Cycle Management technology and services, announced today that it has secured a contract to provide its Revenue Recovery Services to one of East Texas' preferred health care providers.
Endocyte, Inc., a biopharmaceutical company developing targeted small-molecule drug conjugates, announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock.
The ATS has issued an official statement that outlines the Society's position on research, training, education, patient care and advocacy. The statement, which appears in the November 15 issue of the American Journal of Respiratory and Critical Care Medicine, also makes specific recommendations on how elements of the organization can make these policies a part of new and ongoing projects.
Leti, a technology research institute of CEA Tech, today announced a European Union project to develop a nanotherapy targeting the molecules involved in inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis.
› Verified 4 days ago